Catalyst Wire Dossier Catalyst Wire Dossier

SOHONOS

PALOVAROTENE · Ipsen Biopharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SOHONOS, covering 2023-08-16 to 2025-03-13. Get the full timeline:

Most recent: FDA Approved: SOHONOS — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

See pricing